Anatomical and functional outcomes of pneumatic vitreolysis for treatment of vitreomacular traction with and without macular holes

被引:9
作者
Baumann, Carmen [1 ]
Sabatino, Francesco [2 ]
Zheng, Yalin [3 ]
Johannigmann-Malek, Navid [1 ]
Maier, Mathias [1 ]
Kaye, Stephen B. [3 ]
Patton, Niall [2 ]
机构
[1] Tech Univ Munich TUM, Hosp Rechts Isar, Dept Ophthalmol, Ismaninger Str 22, D-81675 Munich, Germany
[2] Manchester Royal Eye Hosp, Oxford Rd, Manchester M13 9WL, Lancs, England
[3] Univ Liverpool, William Henry Duncan Bldg,6 West Derby St, Liverpool L7 8TX, Merseyside, England
关键词
Pneumatic vitreolysis; Vitreomacular traction; Macular hole; OPTICAL COHERENCE TOMOGRAPHY; INTRAVITREAL OCRIPLASMIN; PERFLUOROPROPANE C3F8; GAS; INJECTION;
D O I
10.1007/s00417-022-05568-y
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Purpose To evaluate the outcome of pneumatic vitreolysis (PVL) for vitreomacular traction (VMT) with or without full thickness macular hole (MH) < 400 mu m. Methods Forty-seven eyes of 47 patients were included who had undergone PVL for VMT with or without MH. Main outcome measures were release of VMT, MH closure, best-corrected visual acuity (BCVA) and adverse events. Results Thirty-three patients had isolated VMT and 14 patients VMT with a MH. Four weeks after PVL, the overall VMT release rate was 35/47 (74.5%): 25/37 (67.6%) in phakic and 10/10 (100%) in pseudophakic eyes (p = 0.03). Four of 14 MH (28.6%) were closed. Twenty-two of 47 (46.8%) eyes required a subsequent PPV: 12/33 (36.4%) in the VMT only group and 10/14 (71.4%) in the VMT with MH group. Mean BCVA improved from 0.48 (+/- 0.24) to 0.34 (+/- 0.23) logMAR at 6 months in patients with VMT alone (p < 0.001), and from 0.57 (+/- 0.27) to 0.41 (+/- 0.28) logMAR in patients with VMT and MH (p = 0.008). Adverse events included new formation of a large MH in 4/33 (12.1%) eyes, failure of MH closure in 10/14 (71.4%) eyes, progression of mean minimum linear diameter (MLD) MH size from baseline 139 (+/- 67) to 396 (+/- 130) mu m (p < 0.001) and development of a retinal detachment in 4/47 (8.5%) eyes. Conclusion While PVL leads to a high VMT release rate particularly in pseudophakic eyes, it is associated with a relatively high incidence of MH formation, MH size progression and retinal detachment.
引用
收藏
页码:2209 / 2215
页数:7
相关论文
共 50 条
  • [41] Cost Evaluation of Surgical and Pharmaceutical Options in Treatment for Vitreomacular Adhesions and Macular Holes
    Chang, Jonathan S.
    Smiddy, William E.
    OPHTHALMOLOGY, 2014, 121 (09) : 1720 - 1726
  • [42] Resolution of outer retinal abnormalities in eyes with vitreomacular traction without macular hole in the OASIS trial
    Thomas, Akshay S.
    Duchateau, Luc
    Kozma-Wiebe, Petra
    Jaffe, Glenn
    BRITISH JOURNAL OF OPHTHALMOLOGY, 2023, 107 (07) : 1012 - 1017
  • [43] Anatomical and Functional Changes in the Coexistence of Vitreomacular Traction and Epiretinal Membrane: A Spectral-Domain Optical Coherence Tomography Study
    Chatziralli, Irini
    Theodossiadis, George
    Datseris, Ioannis
    Parikakis, Efstratios
    Theodossiadis, Panagiotis
    OPHTHALMIC RESEARCH, 2017, 57 (01) : 54 - 59
  • [44] To evaluate the functional and anatomical outcomes for autologous retinal autograft with Finesse™ Flex Loop for failed macular holes
    Dhami, Abhinav
    Sharma, Pragya
    Dhami, Nimrata B.
    Dhami, Gobinder S.
    INDIAN JOURNAL OF OPHTHALMOLOGY, 2022, 70 (08) : 3033 - 3037
  • [45] OPTICAL COHERENCE TOMOGRAPHY FEATURES ASSOCIATED WITH VITREOMACULAR TRACTION RELEASE AND MACULAR HOLE SIZE PROGRESSION FOLLOWING TREATMENT WITH OCRIPLASMIN
    Johannigmann-Malek, Navid
    Iannetta, Danilo
    Zheng, Yalin
    Kaye, Stephen B.
    Groselli, Sofia
    Kirchmair, Katharina
    Dervenis, Nikolaos
    Issa, Peter Charbel
    Baumann, Carmen
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2024, 44 (11): : 1923 - 1930
  • [46] VITREOMACULAR TRACTION AFFECTS ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR TREATMENT OUTCOMES FOR EXUDATIVE AGE-RELATED MACULAR DEGENERATION
    Krishnan, Radhika
    Arora, Rashi
    De Salvo, Gabriella
    Stinghe, Alina
    Severn, Philip S.
    Pal, Bishwanath
    Goverdhan, Srinivas
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2015, 35 (09): : 1750 - 1756
  • [47] Pharmacologic vitreolysis for vitreomacular traction syndrome and macular hole: From clinical trials to clinical practice; [Pharmakologische Vitreolyse für das vitreomakuläre Traktionssyndrom und das Makulaforamen: Von klinischen Studien zur klinischen Praxis]
    Manousaridis K.
    Peter-Reichart S.
    Mennel S.
    Spektrum der Augenheilkunde, 2018, 32 (1) : 18 - 24
  • [48] Direct cost of pars plana vitrectomy for the treatment of macular hole, epiretinal membrane and vitreomacular traction: a bottom-up approach
    Elena Nicod
    Timothy L. Jackson
    Federico Grimaccia
    Aris Angelis
    Marc Costen
    Richard Haynes
    Edward Hughes
    Edward Pringle
    Hadi Zambarakji
    Panos Kanavos
    The European Journal of Health Economics, 2016, 17 : 991 - 999
  • [49] Direct cost of pars plana vitrectomy for the treatment of macular hole, epiretinal membrane and vitreomacular traction: a bottom-up approach
    Nicod, Elena
    Jackson, Timothy L.
    Grimaccia, Federico
    Angelis, Aris
    Costen, Marc
    Haynes, Richard
    Hughes, Edward
    Pringle, Edward
    Zambarakji, Hadi
    Kanavos, Panos
    EUROPEAN JOURNAL OF HEALTH ECONOMICS, 2016, 17 (08) : 991 - 999
  • [50] Surgical management of macular holes: techniques, outcomes, and treatment of special cases
    Kassotis, Alexis
    Ramakrishnan, Meera
    Tezel, Tongalp H.
    EXPERT REVIEW OF OPHTHALMOLOGY, 2023, 18 (06) : 391 - 403